Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-21-000037 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
564.93% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.69% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.36% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
55.08% · CORE · NOT_ENOUGH_HISTORY
Gross margin 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
78.26% · CORE · VALID
Operating margin 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-34.32% · CORE · VALID
R&D intensity 100th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.59% · OPTIONAL · VALID
SBC intensity 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
39.08% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 613.25%
Current 564.93%
Delta -48.32% Capex Intensity Increased
Previous 6.25%
Current 6.69%
Delta 0.44% Cash Generation Decreased
Previous 37.55%
Current 19.36%
Delta -18.19% Growth Increased
Previous 52.34%
Current 55.08%
Delta 2.73% Margin Increased
Previous 77.75%
Current 78.26%
Delta 0.52% Profitability Decreased
Previous -29.93%
Current -34.32%
Delta -4.39% R And D Intensity Increased
Previous 25.09%
Current 26.59%
Delta 1.50% Sbc Intensity Decreased
Previous 40.11%
Current 39.08%
Delta -1.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.